Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors. - Wikidata - awgldk - TriplyDB

Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.

Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.

http://www.wikidata.org/entity/Q34706749

about

The Microbial Hypothesis: Contributions of Adenovirus Infection and Metabolic Endotoxaemia to the Pathogenesis of Obesity Serum-dependence of affinity-mediated VEGF release from biomimetic microspheres Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation.Design of growth factor sequestering biomaterials Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models IL12Rβ1ΔTM is a secreted product of il12rb1 that promotes control of extrapulmonary tuberculosis CD69 is the crucial regulator of intestinal inflammation: a new target molecule for IBD treatment?Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration.Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium.The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.Altered expression of endogenous soluble vascular endothelial growth factor receptor-2 is involved in the progression of esophageal squamous cell carcinoma.Nutrition in pelvic radiation disease and inflammatory bowel disease: similarities and differences.Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5 Specific tumor-stroma interactions of EBV-positive Burkitt's lymphoma cells in the chick chorioallantoic membrane.Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?Regulation of soluble VEGFR-2 secreted by microvascular endothelial cells derived from human BPH.A prospective study of immune and inflammation markers and risk of lung cancer among female never smokers in Shanghai.Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1.Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses.Soluble VEGF receptor 1 promotes endothelial injury in children and adolescents with lupus nephritis.The Role of Limbal Epithelial Stem Cells in Regulating Corneal (Lymph)angiogenic Privilege and the Micromilieu of the Limbal Niche following UV Exposure.

P2860

Q28067835-E4B294D3-14BA-405D-8B37-93A6D037AE90 Q33761778-FB2E3FD8-E005-467A-8B61-3617C7B9A392 Q33834038-DC94ED9C-AE07-4BE4-89DA-442837CC96FE Q34543371-C8FC416A-E960-4B8B-83E1-5C6438564229 Q34788361-B7BC709D-B74F-4F7C-A75F-48EE03426073 Q34955491-499972F8-40B9-4A26-86E4-6FCE5ABD97FD Q35155979-612C5161-84E0-45CD-9CFD-2E1157F0482F Q35928528-ACB7E69B-03C4-428E-BD91-E41669794CA5 Q36393036-824572EF-C9EE-4B4C-BC9C-79E401118614 Q36589860-A70CD353-B000-4061-96EC-5E4869155DBA Q36796299-09DC6B1A-0186-424F-B782-F51B3157B2D5 Q38225147-942BFF1E-BD2C-471F-9F32-E767A554D7AE Q39044537-F62BE810-4839-41D5-9083-B3F5C183C468 Q42547317-DB35F836-6AC1-4C27-B779-F2F1A0CF4E30 Q42558684-4B4941EA-AA2F-4B11-AA73-5D6BD86CED85 Q44479059-6C81B663-99C0-4B40-BBF2-EEE9E7CFB7D5 Q47618925-DD3EEF07-852F-4D95-BE37-7B885D3AF823 Q48128395-AEBBF32E-B61B-493D-972D-F10076B66515 Q52718642-FB102C51-1D0C-4A6F-A85A-3786F09ACA6E Q54545016-6C8E7A9F-6E57-4DF9-9799-CFC7502AD8AD Q55177567-5A1C669F-C969-4C51-AC74-9AFA623FD7D2

P2860

Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.

http://www.wikidata.org/entity/Q34706749

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.

@ast

Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.

@en

Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.

@nl

type

label

Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.

@ast

Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.

@en

Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.

@nl

prefLabel

Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.

@ast

Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.

@en

Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.

@nl

P1433

Q34706749-26647F39-3175-40BE-9E6B-564F9298F0DB

P1476

Q34706749-7975078E-13DA-40D6-9ECB-B5502F8D5422

P2093

Q34706749-19ECB16F-D187-48D8-83C0-13FD3E1DA6EF

Q34706749-3D7A226B-54DC-426D-B242-77EE61018E81

Q34706749-95FC9760-89BE-45F1-829D-2124BE6F95AA

Q34706749-A8456024-7660-4209-AD5D-1401BE9E6003

P2860

Q34706749-070841F8-E93A-40A7-8B4F-BED662CC9AE7

Q34706749-08692957-6385-4FDD-B30F-88D08B3C1CE0

Q34706749-1036768E-FF5C-4610-B075-E4A735222BB9

Q34706749-1FF5D92F-C6F0-4987-B01D-B82C55CB3157

Q34706749-238CE514-7614-4465-B074-22C6FC690101

Q34706749-26E59253-E9A5-4B9C-BC85-BCF28712DD2A

Q34706749-3B5A8AE3-5694-4E3F-91EB-CDC683AE271A

Q34706749-493215D1-4900-4DED-AF33-35C5B7089842

Q34706749-4F796D88-1403-4C79-91B2-EE1F345E1331

Q34706749-5FED8EB4-ED51-412C-9B14-EC6ABF36CCA4

P304

Q34706749-7E8C5969-5837-40D5-8B1C-0C37769B24D1

P31

Q34706749-A5317DBF-7B4E-4D04-A034-168EEF3109D8

P356

Q34706749-96FFB34B-42FE-4735-B322-77F72331A711

P407

Q34706749-D07D8C23-2037-41A5-8DC8-868B30D9520D

P478

Q34706749-DBF941F1-C502-421D-B86D-DE8A872232B3

P50

Q34706749-B76992E8-1D39-416B-8F64-347A9CAB5A17

P577

Q34706749-1D25FE83-ADEC-4759-BE01-16D4318E1E98

P5875

Q34706749-38647D7F-8A6C-47C1-A00F-4F8CB9FC1BF2

P698

Q34706749-63E166B5-5094-421D-A604-F943C6F7C1D6

P932

Q34706749-C7A11655-1A59-4C9B-B52F-57C97442B798

P356

J.1749-6632.2010.05714.X

P1433

Annals of the New York Academy of Sciences

P1476

Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors

@en

P2093

Helena Pavlakovic

http://www.w3.org/2001/XMLSchema#string

Jayakrishna Ambati

http://www.w3.org/2001/XMLSchema#string

Jörg Wilting

http://www.w3.org/2001/XMLSchema#string

Romulo Albuquerque

http://www.w3.org/2001/XMLSchema#string

P2860

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cells

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling

The biology of VEGF and its receptors

The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

Structure and function of VEGF receptors

P304

E7-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.2010.05714.X

http://www.w3.org/2001/XMLSchema#string

P407

P478

1207 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47542641

http://www.w3.org/2001/XMLSchema#string

P698

20961309

http://www.w3.org/2001/XMLSchema#string

P932

3062194

http://www.w3.org/2001/XMLSchema#string